Tuesday, August 25, 2026
12:00 p.m. – 1:00 p.m. ET
Please note this program starts at 12:00 p.m. Eastern, 11:00 a.m. Central, 10:00 a.m. Mountain 9:00 a.m. Pacific
PRESENTING FACULTY
 |
Lucia M. Novak MSN, CRNP, ANP-BC, BC-ADM, FAANP President, Diabesity LLC, North Bethesda, Maryland Co-Executive Director, Capital Health and Metabolic Center, Capital Diabetes and Endocrine Associates, Silver Spring, Maryland Diabetologist, Stability Health, Worcester, Massachusetts |
PROGRAM OVERVIEW
This activity is designed to help healthcare professionals overcome clinical inertia and psychological barriers to insulin use in patients with type 2 diabetes. It explores practical approaches to integrating basal insulin therapy, including considerations for mechanistic differences, time in range, and glycemic variability. The program also examines current guidelines and best practices for timely treatment intensification in high-risk patients to support improved long-term outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of primary care physicians, internal medicine physicians, nurse practitioners, physician assistants, pharmacists, certified diabetes care and education specialists/nurses, new residents and fellows, managed care professionals, and patients in the United States (US) with interest in optimizing management of T2DM.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
· Identify factors that contribute to clinical inertia, including psychological insulin resistance, and how to address these barriers in clinical management of patients with T2DM
· Integrate BI therapies along with considerations for mechanistic characteristics, TIR, and glycemic variability to inform treatment strategies
· Apply guidelines to select and appropriately intensify BI therapy for high-risk populations with T2DM
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this virtually live activity for a maximum of 1.0 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
ACCME INNOVATION PARTNER DISCLAIMER
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact: Med Learning Group at [email protected].
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
